COVID-19 as an Emerging Infectious Disease and its Variants

The COVID-19 pandemic, driven by SARS-CoV-2, has profoundly impacted global health, economies, and daily life since late 2019. This review explores the virus’s origin, transmission, and evolution, focusing on key variants-Alpha, Beta, Gamma, Delta, and Omicronhighlighting their genetic mutations, transmissibility, and clinical outcomes. It addresses diagnostic challenges, shifting epidemiological patterns, and the impact of emerging variants on test reliability. The review also evaluates current treatments, vaccination efforts, and public health strategies, emphasizing the influence of viral mutations. The study underscores how SARS-CoV-2 variants have shaped the global COVID-19 pandemic, influencing its clinical impact and presenting ongoing challenges to diagnosis, treatment, and vaccination efforts. Furthermore, it emphasizes the need for continuous surveillance, adaptable healthcare strategies, and global cooperation to mitigate future threats, while strengthening diagnostics, healthcare systems, and equitable access to therapeutics.